scispace - formally typeset
Journal ArticleDOI

A new tool for technical standardization of the Ki67 immunohistochemical assay.

Reads0
Chats0
TLDR
In this article, a cell line microarray system was developed for the standardization of the Karpas 299 or Jurkat cells (Ki67+) with Sf9 (Spodoptera frugiperda) (ki67-) cells in incremental standardized ratios.
About
This article is published in Modern Pathology.The article was published on 2021-02-03. It has received 17 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer

TL;DR: In this paper, the authors discuss the clinical utility, current pitfalls, and promising strategies to augment the Ki-67 proliferation indices in future breast oncology, and discuss the current pitfalls and promising solutions to augment it.
Journal ArticleDOI

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

TL;DR: In this paper , an automated digital image analysis (DIA) platform was used to evaluate tumoral Ki67 expression in breast cancer patients using a set of 60 previously stained slides containing 30 core-cut biopsy and 30 corresponding resection specimens.
Journal ArticleDOI

Challenging, Accurate and Feasible: CAF-1 as a Tumour Proliferation Marker of Diagnostic and Prognostic Value

TL;DR: In this article, the authors reviewed recent evidence demonstrating that chromatin assembly factor 1 (CAF-1), a histone chaperone selectively expressed in cycling cells, is a proliferation marker of clinical value, when evaluated by immunocytochemistry in breast cancer cytology smears and immunohistochemistry in cancer biopsies from several tissues, strongly correlates with the expression of Ki-67 and other proliferation markers.
Journal ArticleDOI

Compound computer vision workflow for efficient and automated immunohistochemical analysis of whole slide images

TL;DR: A fully automated workflow for quantifying Ki-67, a standard IHC test used to assess cell proliferation on digital whole slide images (WSIs), is developed to show how innovations in computer vision can be serially compounded to automate and improve implementation in clinical workflows.
References
More filters
Journal Article

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

TL;DR: The data suggest that the early stages of mitogen stimulation represent initial sequences of proliferation and not parts of the cell cycle, and immunostaining with monoclonal antibody Ki-67 provides a reliable means of rapidly evaluating the growth fraction of normal and neoplastic human cell populations.
Journal ArticleDOI

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

TL;DR: Broad treatment recommendations are presented, recognizing that detailed treatment decisions need to consider disease extent, host factors, patient preferences, and social and economic constraints.
Journal ArticleDOI

QuPath: Open source software for digital pathology image analysis

TL;DR: QuPath provides researchers with powerful batch-processing and scripting functionality, and an extensible platform with which to develop and share new algorithms to analyze complex tissue images, making it suitable for a wide range of additional image analysis applications across biomedical research.
Journal ArticleDOI

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

TL;DR: A graphical method is developed, the X-tile plot, that illustrates the presence of substantial tumor subpopulations and shows the robustness of the relationship between a biomarker and outcome by construction of a two dimensional projection of every possible subpopulation.
Journal ArticleDOI

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

TL;DR: Thirteen categories of breast tumor markers were considered, six of which were new for the guideline, and certain multiparameter gene expression assays not all applications for these markers were supported, however.
Related Papers (5)